Sort
141,003 grants matching “cytokine”
Protection Against Inhalation Anthrax with Inactivated Spores
$997,616Donald G. Guiney · University Of California, San Diego · U01 · FY2009 · AI
The Environmental Triggers of Diabetes (TEDDY) in Sweden
$997,608Ake Lernmark · Lunds Universitet · U01 · FY2008 · DK
ErythroMer: Nanoscale BioSynthetic Red Cell Substitute
$997,590Esma Alp · Kalocyte, Inc. · R44 · FY2024 · HL
Immunity and Healthy Aging
$997,557Abbe N De Vallejo · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · AG
Anti-HIV Microbicide: Cellulose Acetate Phthalate (CAP)
$997,525New York Blood Center · P01 · FY2004 · HD
OTHER FUNCTIONS - PINCER-BASED IN-PROCESS ANALYZER FOR BIOLOGICS
$997,251Ling Tian · Mediomics, Llc · N44 · FY2012 · CA
Targeting lipid rafts for treatment of asthma
$997,203Yakov Kogan · Raft Pharmaceuticals, Llc · R44 · FY2024 · AI
Impact of obesity on SARS-CoV-2 infection and reciprocal effects of SARS-CoV-2 on metabolic disease
$997,077Charles T Roberts · Oregon Health & Science University · R01 · FY2025 · DK
All-Human Microphysical Model of Metastasis Therapy
$996,993Linda G. Griffith · Massachusetts Institute Of Technology · UH3 · FY2016 · TR
Development of DRα1-MOG-35-55 for treatment of DR2 negative MS subjects
$996,926Jeffrey S King · Virogenomics Biodevelopment, Inc. · R44 · FY2021 · AI
The Northeast Center for Agricultural Health
$996,761John J May · Mary Imogene Bassett Hospital · U50 · FY2006 · OH
Systemic regulation of metastasis
$996,660David Charles Lyden · Weill Medical Coll Of Cornell Univ · R35 · FY2022 · CA
Development of DRα1-MOG-35-55 for treatment of DR2 negative MS subjects
$996,486Renee Lynn Shirley · Virogenomics Biodevelopment, Inc. · R44 · FY2022 · AI
XT-101: A Novel and Potent Non-Opioid Treatment for Neuropathic Pain
$996,485Raymond A. Chavez · Xalud Therapeutics, Inc. · U44 · FY2012 · NS
Multi-Omic Single-Cell System for Improved Combination Cancer Immunotherapy Monitoring and Implementation
$996,470Timothy S McConnell · Isoplexis, Inc. · R44 · FY2019 · CA
Host Directed Orynotide for MDR Gram Negative Bacterial Infections
$996,458Justin Blaine Schaal · University Of Southern California · R01 · FY2024 · AI
Immunomodulatory Therapy for Neuropathic Pain
$996,399Ridong Chen · Apt Therapeutics, Inc. · R44 · FY2021 · NS
Small Molecule Antagonists of PF4 for the Treatment and Prevention of HIT
$996,228Jay Edward Wrobel · Fox Chase Chemical Diversity Center, Inc · R44 · FY2020 · HL
Targeting leukocyte metabolism to treat human autoimmune disease
$996,128Jay L Rothstein · Immunext, Inc. · R44 · FY2019 · AI
Subclinical Vascular Disease and Metabolic Abnormalities in MACS
$996,118Wendy S Post · Johns Hopkins University · R01 · FY2011 · HL
Mechanistic studies on stress, brain inflammation and neuroprotection
$996,062Juan M Saavedra · National Institute Of Mental Health · ZIA · FY2012 · MH
Innate Immune Protection by Clean Genome E. coli
$995,989Frederick R Blattner · Scarab Genomics, Llc · R44 · FY2011 · AI
New BDNF Nanoparticles for Early Treatment of Alzheimer's Disease
$995,987Franco Vitaliano · Exqor Technologies, Inc. · R44 · FY2023 · AG
New BDNF Nanoparticles for Early Treatment of Alzheimer's Disease
$995,987Franco Vitaliano · Exqor Technologies, Inc. · R44 · FY2024 · AG
pRBC Contaminant Removal with Hemocompatible Porous Polymer Beads
$995,984Phillip Chan · Cytosorbents, Inc. · R44 · FY2018 · HL